Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8
2019 · Anti-Cancer Agents in Medicinal Chemistry · 17 citations
https://doi.org/10.2174/1871520619666190307120811
L
Lifang Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
431
Citations
10
h-index
11
i10-index
Lifang Liu is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Breast Cancer Treatment Studies & Breast Lesions and Carcinomas. The author has an h-index of 10, co-authored 25 publications.
ORCID: 0000-0002-1065-314XPapers by this author
worksThe RDV P2 protein interacts with OsIAA10.
2016 · Figshare · 0 citations
https://doi.org/10.1371/journal.ppat.1005847.g002
Representativeness of trial participants: linking the EORTC boost-no boost trial to the Netherlands cancer registry
2022 · Journal of Clinical Epidemiology · 0 citations
https://doi.org/10.1016/j.jclinepi.2022.04.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat